InflaRx N.V.
NASDAQInflaRx enters its May 7 results carrying a month-long price surge and a borrow market that has quietly loosened — a setup that puts the clinical pipeline firmly in the spotlight. The stock's 116% one-month gain to $1.97 is the dominant fact of the week. That move has come with real volatility: the stock gave back 7.5% on Tuesday alone, after posting an 18% gain over the prior five…
Snapshot as of 7 May 2026
InflaRx enters its May 7 results carrying a month-long price surge and a borrow market that has quietly loosened — a setup that puts the clinical pipeline firmly in the spotlight. The stock's 116% one-month gain to…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IFRX — free to start on ORTEX.
Sign up for free →Open IFRX on ORTEX